Study Shows PFCs Can Reduce Vaccine Effectiveness – Voice of America
Study Shows PFCs Can Reduce Vaccine Effectiveness Voice of America When children are vaccinated their immune systems produce antibodies that protect them from debilitating and potentially deadly childhood infections, such as polio, measles, diphtheria and tetanus. The protection is supposed to last a lifetime. |
The W100 pocket on HIV-1 gp120 penetrated by b12 is not a target for other … – 7thSpace Interactive (press release)
The W100 pocket on HIV-1 gp120 penetrated by b12 is not a target for other ... 7thSpace Interactive (press release) FindingsAll CD4bs mabs tested blocked soluble CD4 binding to gp120 consistent with their designation as CD4bs directed antibodies. All CD4bs mabs tested neutralized pseudovirions carrying NL4.3 wt envelope. However, only b12 failed to neutralize ... |
New Psoriasis Guidelines Expand Treatment Options – MedPage Today
New Psoriasis Guidelines Expand Treatment Options MedPage Today Point out that conventional drugs such as methotrexate and cyclosporine often are effective, but have significant toxicities, including liver problems with methotrexate and kidney problems with cyclosporine. Newer biologic agents for treating ... |
The Top Myeloma Beacon Patient And Caregiver Columns Of 2011 – The Myeloma Beacon
The Top Myeloma Beacon Patient And Caregiver Columns Of 2011 The Myeloma Beacon My Stem Cell Transplant – In another column, Dr. Goodman described the stem cell transplant process for patients who may be considering one. He also wrote about his personal experience with an outpatient transplant, and how he needed to be admitted to ... |
Nanotech transforms cyclosporine into safer transplant drug – FierceDrugDelivery
 Nanotechnology News | Nanotech transforms cyclosporine into safer transplant drug FierceDrugDelivery The Times of India reports that researchers at the University of Strathclyde in Scotland are working on a nano-sized drug particle version of cyclosporine, which is used already to help prevent organ rejection. Doctors would encapsulate the drug inside ... Nano drug delivery to eliminate transplant failures |
FDA Approves Inlyta To Treat Patients With a Type of Advanced Kidney Cancer – Sacramento Bee
 WANE | FDA Approves Inlyta To Treat Patients With a Type of Advanced Kidney Cancer Sacramento Bee Recently approved drugs for the treatment of kidney cancer include sorafenib (2005), sunitinib (2006), temsirolimus (2007), everolimus (2009), bevacizumab (2009) and pazopanib (2009). The safety and effectiveness of Inlyta were evaluated in a single ... FDA Approves Axitinib for Advanced Kidney Cancer FDA OKs Axitinib for Kidney Cancer |
Steroid-Sparing Renal Transplant Yields Successful Outcomes – Doctors Lounge
Steroid-Sparing Renal Transplant Yields Successful Outcomes Doctors Lounge Acute rejection rates were 31 and 25 percent, respectively, and chronic rejection due to interstitial fibrosis/tubular atrophy occurred in 47 and 39 percent of LD and DD recipients, respectively. For patients who underwent RDP after renal ... |
Sycamore Shoals Hospital receives certification for congestive heart failure … – Elizabethton Star
Sycamore Shoals Hospital receives certification for congestive heart failure ... Elizabethton Star By Ashley Rader Sycamore Shoals Hospital recently received the Joint Commission's Advanced Certification for congestive heart failure for its high-quality care to patients with this disease. It is the first hospital in the MSHA system to have reached ... Readmission rate culprits remain elusive |
Regenerative medicine company encouraged by heart failure trial – MedCity News
Regenerative medicine company encouraged by heart failure trial MedCity News Regenerative medicine company Juventas Therapeutics is touting the results from 12-month data of a phase 1 clinical trial of heart failure patients. At 12 months, heart failure patients treated with the company's stem cell therapy showed “significant” ... |
Kidney Donor Gives Organ to Stranger on a Whim – ABC News
 ABC News | Kidney Donor Gives Organ to Stranger on a Whim ABC News But last June, the 55-year-old professor gave doctoral student John Young -- a virtual stranger -- her kidney, enduring every invasive test and eventually transplant surgery to save his life. As Oyler tells it, her decision was rooted in compassion but ... |